This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's confusion, asterixis, and paracentesis with PMN 320 cells/mm³ suggest spontaneous bacterial peritonitis precipitating encephalopathy, requiring immediate assessment and treatment to prevent complications. The correct choice, starting IV ceftriaxone for spontaneous bacterial peritonitis, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, beginning propranolol immediately to prevent variceal bleeding, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.

This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's cirrhosis and risk for hepatocellular carcinoma suggest need for surveillance, requiring immediate assessment and treatment to prevent complications. The correct choice, ultrasound of the liver every 6 months with or without AFP, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, no surveillance is needed after hepatitis C cure, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.

This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's history of SBP suggests need for prophylaxis, requiring immediate assessment and treatment to prevent complications. The correct choice, starting long-term SBP prophylaxis with oral antibiotic therapy, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, no prophylaxis is needed if symptoms resolve, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.

Current guidelines for primary prophylaxis of variceal bleeding recommend that patients with compensated cirrhosis and small varices without high-risk stigmata (e.g., red wale signs) do not require immediate treatment with non-selective beta-blockers or band ligation. The recommended approach is surveillance with a repeat EGD in 1-2 years to monitor for an increase in variceal size, which would then prompt initiation of prophylactic therapy. Beta-blockers are typically reserved for medium/large varices or decompensated cirrhosis.

The patient's ascitic fluid PMN count is 45 cells/mm³ (150 * 0.30), which is below the diagnostic threshold for SBP (>250 cells/mm³). However, long-term SBP prophylaxis is indicated in patients with ascites who have a low ascitic fluid protein concentration (<1.5 g/dL) because this indicates a deficit in ascitic fluid opsonic activity, increasing infection risk. This patient's protein is 0.8 g/dL, meeting the criteria for primary prophylaxis. Daily ciprofloxacin or norfloxacin is a standard regimen.

For a newly detected liver lesion between 1 and 2 cm in a cirrhotic patient, the standard diagnostic algorithm requires further characterization with multiphasic cross-sectional imaging (either a 4-phase CT or dynamic contrast-enhanced MRI). These studies can identify the characteristic vascular features of hepatocellular carcinoma (HCC), such as arterial phase hyperenhancement and venous/delayed phase washout, which can be diagnostic without a biopsy. Repeating the ultrasound is an unacceptable delay, biopsy is reserved for indeterminate lesions on cross-sectional imaging, and TACE is a treatment, not a diagnostic step.

The patient presents with signs of overt hepatic encephalopathy (HE). In patients with known cirrhosis, it is crucial to identify and treat the precipitating cause. Common precipitants include infection (e.g., SBP), GI bleeding, electrolyte disturbances, new psychoactive medications, and constipation. The history explicitly mentions four days of constipation, which leads to increased intestinal production and absorption of ammonia, making it the most likely cause in this scenario.

This patient has refractory ascites. The primary treatment options are serial large-volume paracentesis (LVP) or TIPS. Since she is already requiring frequent LVP, TIPS is the definitive next step to consider for long-term control. It decompresses the portal system, reducing ascites formation. In a patient with a reasonable MELD score and no history of encephalopathy, TIPS is an excellent option. Midodrine is for HRS, albumin infusions are not a standard long-term strategy, and indwelling catheters have a very high infection risk.

Non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen should be avoided in patients with cirrhosis. NSAIDs inhibit prostaglandin synthesis, which is critical for maintaining renal blood flow in the setting of portal hypertension and splanchnic vasodilation. Their use can precipitate acute kidney injury and hepatorenal syndrome. They also increase the risk of gastrointestinal bleeding. Acetaminophen is safe at reduced doses (≤2 g/day), tramadol can be used cautiously, and topical agents are safe.

The patient's clinical presentation is classic for hepatopulmonary syndrome (HPS). The pathognomonic finding is platypnea-orthodeoxia: dyspnea (platypnea) and hypoxemia (orthodeoxia) that are worse in the upright position and improve with lying down. This occurs due to intrapulmonary vascular dilatations that are most pronounced at the lung bases, leading to increased shunting and V/Q mismatch in the upright posture. Hepatic hydrothorax would cause dyspnea but not the positional desaturation, and portopulmonary hypertension presents with signs of right heart failure.